Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results 2024 Dec;39(16):3217-3224. doi: 10.1007/s11606-024-08943-z. Epub 2024-07-25. PubMed
Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study 2024 Dec;39(16):3205-3216. doi: 10.1007/s11606-024-08764-0. Epub 2024-05-21. PubMed
Wernli KJ, Haupt EC, Chawla N, Osuji T, Shen E, Smitherman AB, Casperson M, Kirchhoff AC, Zebrack BJ, Keegan THM, Kushi L, Baggett C, Kaddas HK, Ruddy KJ, Sauder CAM, Wun T, Figueroa Gray M, Chubak J, Nichols H, Hahn EE Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020 2024 Oct;13(5):738-747. doi: 10.1089/jayao.2023.0174. Epub 2024-04-29. PubMed
Figueroa Gray MS, Shapiro L, Dorsey CN, Randall S, Casperson M, Chawla N, Zebrack B, Fujii MM, Hahn EE, Keegan THM, Kirchhoff AC, Kushi LH, Nichols HB, Wernli KJ, Sauder CAM, Chubak J A Patient-Centered Conceptual Model of AYA Cancer Survivorship Care Informed by a Qualitative Interview Study 2024 Sep 4;16(17). doi: 10.3390/cancers16173073. Epub 2024-09-04. PubMed
Lu Y, Tong J, Chubak J, Lumley T, Hubbard RA, Xu H, Chen Y Leveraging error-prone algorithm-derived phenotypes: Enhancing association studies for risk factors in EHR data 2024 Sep;157:104690. doi: 10.1016/j.jbi.2024.104690. Epub 2024-07-14. PubMed
Alimena S, Lykken JM, Tiro JA, Chubak J, Haas JS, Werner C, Kobrin SC, Silver MI, Perkins RB, Feldman S Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record 2024 Sep;1(3):32. doi: 10.1097/og9.0000000000000032. Epub 2024-09-19. PubMed
Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large, Community-based Setting 2024 Aug;119(8):1590-1599. doi: 10.14309/ajg.0000000000002721. Epub 2024-02-14. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.